Life Sciences manufacturers are exploring emerging pricing and commercial models in response to an increasing competitive marketplace dynamic, pricing pressures and patient needs. 

While there’s no magic bullet for pricing challenges, manufacturers and payers are finding that creative financial models are helping patients access prescription medications. These evolving pricing models stand on their own or involve contracts in the case of value- and outcome-based models

Several important pricing models and contracts have emerged at the forefront for Life Sciences companies. As such, you will be forced to adopt more flexible pricing strategies and contracts with the same level of flexibility.